Stock Watch: Hesitant Vaccine Sales For CSL Reflect Wider Issues
Lower Influenza Vaccine Trends Are Mimicked By Other Shots
CSL’s US influenza vaccine sales were a window into wider issues for vaccine manufacturers that had already impacted the fourth-quarter results of Merck, Pfizer and GSK. There could also be a correlation between lower vaccine sales and the measles outbreak in Texas.
